Cover storyFDA’s Proposed DTC Rule Could End TV Drug Ads
FDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.
Cover storyFDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.

FDA cited New York Tong Ren Tang for marketing three unapproved drugs online, including an ophthalmic product flagged as a public health risk.

FDA lab confirms undeclared dexamethasone in New Green Nutrition herbal product, citing four unapproved drugs in October 2026 warning letter.

Lupin launches generic Raltegravir 600 mg in the US with 180-day exclusivity, becoming the sole generic alternative to Merck's Isentress HD.

FDA issued Warning Letter 737558 to Mexico-based Natuzem over three unapproved drugs marketed online with therapeutic claims.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Nov 28
Dec 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

